Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrus Aqueous Implant for Primary Open Angle Glaucoma
NCT03065036Phase 2Completed
- Sponsor
- Ivantis
- Start
- Mar 2010
- Primary completion
- Nov 2013
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial in primary open-angle glaucoma (POAG), sponsored by Ivantis. Primary endpoint: Intraocular Pressure at 1 year. Started Mar 2010; status: completed.
02
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT03065036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065036.